- CA$232.53m
- CA$370.32m
- CA$274.12m
- 55
- 95
- 52
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 190 | 115 | 227 | 323 | 274 |
Cost of Revenue | |||||
Gross Profit | 120 | 56.2 | 156 | 238 | 191 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 168 | 458 | -50.8 | 186 | 190 |
Operating Profit | 21.4 | -343 | 278 | 138 | 84 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.54 | -368 | 233 | 105 | 59.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.98 | -307 | 179 | 79 | 44.9 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 21.9 | -307 | 179 | 79 | 44.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21.9 | -307 | 179 | 79 | 44.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.089 | -2.73 | 0.651 | 2.12 | 1.2 |
Dividends per Share |